标题
Renal cell carcinoma
作者
关键词
-
出版物
Nature Reviews Disease Primers
Volume 3, Issue -, Pages 17009
出版商
Springer Nature
发表日期
2017-03-09
DOI
10.1038/nrdp.2017.9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma
- (2017) James J. Hsieh et al. EUROPEAN UROLOGY
- Renal cell carcinoma: a critical analysis of metabolomic biomarkers emerging from current model systems
- (2017) Daniela Rodrigues et al. Translational Research
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) B. Escudier et al. ANNALS OF ONCOLOGY
- Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma
- (2016) Martin H Voss et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
- (2016) A. Ari Hakimi et al. CANCER CELL
- Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
- (2016) D. J. Kwiatkowski et al. CLINICAL CANCER RESEARCH
- Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs
- (2016) Chung-Han Lee et al. Clinical Genitourinary Cancer
- Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database
- (2016) I. Wolff et al. EJSO
- The Role of Cytoreductive Nephrectomy: European Association of Urology Recommendations in 2016
- (2016) Axel Bex et al. EUROPEAN UROLOGY
- Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial
- (2016) Nizar M. Tannir et al. EUROPEAN UROLOGY
- Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations
- (2016) Gabriel G. Malouf et al. EUROPEAN UROLOGY
- Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy
- (2016) Lorenzo Marconi et al. EUROPEAN UROLOGY
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
- (2016) Holger Moch et al. EUROPEAN UROLOGY
- Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin
- (2016) Jianing Xu et al. JOURNAL OF CLINICAL INVESTIGATION
- Von Hippel-Lindau Disease: Genetics and Role of Genetic Counseling in a Multiple Neoplasia Syndrome
- (2016) Sarah M. Nielsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations
- (2016) Laurence Albiges et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma
- (2016) Thomas Powles et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study
- (2016) Nawar Hanna et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non–Clear Cell Renal Cell Carcinoma
- (2016) Martin H. Voss et al. JOURNAL OF CLINICAL ONCOLOGY
- MP71-03 DEVELOPMENT OF A CLEAR CELL RENAL CELL CARCINOMA XENOGRAFT MODEL: A CASE FOR THE USE OF BIOPSY TISSUE OVER SURGICAL TISSUE
- (2016) Yiyu Dong et al. JOURNAL OF UROLOGY
- Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
- (2016) Naomi B Haas et al. LANCET
- Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial
- (2016) David Cella et al. LANCET ONCOLOGY
- Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
- (2016) Andrew J Armstrong et al. LANCET ONCOLOGY
- Targeting renal cell carcinoma with a HIF-2 antagonist
- (2016) Wenfang Chen et al. NATURE
- On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
- (2016) Hyejin Cho et al. NATURE
- Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
- (2016) Alain Ravaud et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma
- (2016) Maria I. Carlo et al. ONCOLOGIST
- Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma
- (2016) Mark Bi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma
- (2016) Limin Zhang et al. BioScience Trends
- Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets
- (2016) Ying-Bei Chen et al. Nature Communications
- Functional characterization of the 12p12.1 renal cancer-susceptibility locus implicates BHLHE41
- (2016) Pierre Bigot et al. Nature Communications
- Introduction to small renal tumours and prognostic indicators
- (2016) Alessandro Crestani et al. International Journal of Surgery
- Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma
- (2016) Fengju Chen et al. Cell Reports
- Sarcomatoid renal cell carcinoma: genomic insights from sequencing of matched sarcomatous and carcinomatous components
- (2016) Brandon J. Manley et al. Translational Cancer Research
- Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes
- (2016) Stefan Winter et al. Scientific Reports
- Hereditary Renal Cell Carcinoma Syndromes
- (2015) Adebowale J. Adeniran et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients
- (2015) Frede Donskov et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis
- (2015) H. I. Wettersten et al. CANCER RESEARCH
- PD-1 blockade therapy in renal cell carcinoma: Current studies and future promises
- (2015) F. Massari et al. CANCER TREATMENT REVIEWS
- Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
- (2015) N. A. Giraldo et al. CLINICAL CANCER RESEARCH
- Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting
- (2015) B. Beuselinck et al. CLINICAL CANCER RESEARCH
- A Systematic Review of Sequencing and Combinations of Systemic Therapy in Metastatic Renal Cancer
- (2015) Laurence Albiges et al. EUROPEAN UROLOGY
- Systemic Therapy for Non–clear Cell Renal Cell Carcinomas: A Systematic Review and Meta-analysis
- (2015) Francisco E. Vera-Badillo et al. EUROPEAN UROLOGY
- Five-year Analysis of a Multi-institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry
- (2015) Phillip M. Pierorazio et al. EUROPEAN UROLOGY
- Understanding Pathologic Variants of Renal Cell Carcinoma: Distilling Therapeutic Opportunities from Biologic Complexity
- (2015) Brian Shuch et al. EUROPEAN UROLOGY
- International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality
- (2015) Ariana Znaor et al. EUROPEAN UROLOGY
- EAU Guidelines on Renal Cell Carcinoma: 2014 Update
- (2015) Borje Ljungberg et al. EUROPEAN UROLOGY
- A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy
- (2015) Tobias Klatte et al. EUROPEAN UROLOGY
- Oncologic Surveillance After Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based Approach
- (2015) Suzanne B. Stewart-Merrill et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial
- (2015) Robert J Motzer et al. LANCET ONCOLOGY
- A river model to map convergent cancer evolution and guide therapy in RCC
- (2015) Elizabeth Y. Wei et al. Nature Reviews Urology
- Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Toni K. Choueiri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
- (2015) L Zhou et al. ONCOGENE
- SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair
- (2015) N Kanu et al. ONCOGENE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Decreased PBRM1 expression predicts unfavorable prognosis in patients with clear cell renal cell carcinoma
- (2015) Soo Jeong Nam et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Immune signature of tumor infiltrating immune cells in renal cancer
- (2015) Katharina Geissler et al. OncoImmunology
- Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma
- (2015) Jeremiah J. Morrissey et al. JAMA Oncology
- The Global Burden of Cancer 2013
- (2015) Christina Fitzmaurice et al. JAMA Oncology
- Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results
- (2015) Asim Amin et al. Journal for ImmunoTherapy of Cancer
- Metastatic Non-Clear Cell Renal Cell Carcinoma: An Evidence Based Review of Current Treatment Strategies
- (2015) Alexander Sankin et al. Frontiers in Oncology
- The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
- (2014) Caleb F. Davis et al. CANCER CELL
- Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy
- (2014) M. H. Voss et al. CLINICAL CANCER RESEARCH
- ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma
- (2014) Samira A. Brooks et al. EUROPEAN UROLOGY
- Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers
- (2014) Sakshi Gulati et al. EUROPEAN UROLOGY
- Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma
- (2014) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
- (2014) Marco Gerlinger et al. NATURE GENETICS
- Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib
- (2014) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Robotic versus Open Partial Nephrectomy: A Systematic Review and Meta-Analysis
- (2014) Zhenjie Wu et al. PLoS One
- Bap1is essential for kidney function and cooperates withVhlin renal tumorigenesis
- (2014) Shan-Shan Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function benefit even when expanding indications beyond the traditional 4-cm cutoff
- (2014) Géraldine Pignot et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- A Diverse Array of Cancer-Associated MTOR Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity
- (2014) B. C. Grabiner et al. Cancer Discovery
- The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling
- (2014) Alexander Sankin et al. Cancer Medicine
- Hereditary Kidney Cancer Syndromes
- (2013) Naomi B. Haas et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
- (2013) John R. Srigley et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Comparison of peri-operative outcomes of robot-assisted vs laparoscopic partial nephrectomy: a meta-analysis
- (2013) Xiaohua Zhang et al. BJU INTERNATIONAL
- A multicentre matched-pair analysis comparing robot-assisted versus open partial nephrectomy
- (2013) Vincenzo Ficarra et al. BJU INTERNATIONAL
- Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria
- (2013) Nils Kroeger et al. CANCER
- A systematic review of predictive and prognostic biomarkers for VEGF-targeted therapy in renal cell carcinoma
- (2013) Tomohiro Funakoshi et al. CANCER TREATMENT REVIEWS
- Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin
- (2013) R. Remark et al. CLINICAL CANCER RESEARCH
- Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network
- (2013) A. A. Hakimi et al. CLINICAL CANCER RESEARCH
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Sunitinib objective response in metastatic renal cell carcinoma: Analysis of 1059 patients treated on clinical trials
- (2013) A.M. Molina et al. EUROPEAN JOURNAL OF CANCER
- Renal Function After Nephron-sparing Surgery Versus Radical Nephrectomy: Results from EORTC Randomized Trial 30904
- (2013) Emil Scosyrev et al. EUROPEAN UROLOGY
- HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
- (2013) Gregg L. Semenza JOURNAL OF CLINICAL INVESTIGATION
- Defining Early-Onset Kidney Cancer: Implications for Germline and Somatic Mutation Testing and Clinical Management
- (2013) Brian Shuch et al. JOURNAL OF CLINICAL ONCOLOGY
- An Epidemiologic and Genomic Investigation Into the Obesity Paradox in Renal Cell Carcinoma
- (2013) A. Ari Hakimi et al. JNCI-Journal of the National Cancer Institute
- Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation
- (2013) Payal Kapur et al. LANCET ONCOLOGY
- External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
- (2013) Daniel YC Heng et al. LANCET ONCOLOGY
- Integrated molecular analysis of clear-cell renal cell carcinoma
- (2013) Yusuke Sato et al. NATURE GENETICS
- A clear picture of renal cell carcinoma
- (2013) A Ari Hakimi et al. NATURE GENETICS
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- (2013) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiogenomics of Clear Cell Renal Cell Carcinoma: Associations between CT Imaging Features and Mutations
- (2013) Christoph A. Karlo et al. RADIOLOGY
- Non-Clear Cell Renal Cancer: Disease-Based Management and Opportunities for Targeted Therapeutic Approaches
- (2013) W. Marston Linehan et al. SEMINARS IN ONCOLOGY
- Adjuvant Therapy in Renal Cell Carcinoma—Past, Present, and Future
- (2013) Tobias Janowitz et al. SEMINARS IN ONCOLOGY
- A common variant at 8q24.21 is associated with renal cell cancer
- (2013) Julius Gudmundsson et al. Nature Communications
- Evolutionary dynamics of cancer in response to targeted combination therapy
- (2013) Ivana Bozic et al. eLife
- Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies
- (2012) Regina El Dib et al. BJU INTERNATIONAL
- Growth kinetics and active surveillance for small renal masses
- (2012) Brian R. Lane et al. CURRENT OPINION IN UROLOGY
- Systematic Review of Perioperative and Quality-of-life Outcomes Following Surgical Management of Localised Renal Cancer
- (2012) Steven MacLennan et al. EUROPEAN UROLOGY
- Robotic Versus Laparoscopic Partial Nephrectomy: A Systematic Review and Meta-Analysis
- (2012) Omar M. Aboumarzouk et al. EUROPEAN UROLOGY
- A Review of Integrated Staging Systems for Renal Cell Carcinoma
- (2012) Malek Meskawi et al. EUROPEAN UROLOGY
- Systematic Review of Oncological Outcomes Following Surgical Management of Localised Renal Cancer
- (2012) Steven MacLennan et al. EUROPEAN UROLOGY
- Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma
- (2012) A. Ari Hakimi et al. EUROPEAN UROLOGY
- Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer
- (2012) Marc Henrion et al. HUMAN MOLECULAR GENETICS
- Serum Lactate Dehydrogenase Predicts for Overall Survival Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Inhibition of Mammalian Target of Rapamycin
- (2012) Andrew J. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials
- (2012) Hai T Tran et al. LANCET ONCOLOGY
- BAP1 loss defines a new class of renal cell carcinoma
- (2012) Samuel Peña-Llopis et al. NATURE GENETICS
- Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression
- (2012) Johannes Schödel et al. NATURE GENETICS
- Evolution of the cancer genome
- (2012) Lucy R. Yates et al. NATURE REVIEWS GENETICS
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- An overview of renal cell cancer: Pathology and genetics
- (2012) Holger Moch SEMINARS IN CANCER BIOLOGY
- Differential Diagnosis of Renal Tumors With Papillary Architecture
- (2011) Satish K. Tickoo et al. ADVANCES IN ANATOMIC PATHOLOGY
- Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma
- (2011) Ana M. Molina et al. CANCER
- Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy
- (2011) Eric Tartour et al. CANCER AND METASTASIS REVIEWS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Current Pathology Keys of Renal Cell Carcinoma
- (2011) Ferran Algaba et al. EUROPEAN UROLOGY
- Positive Surgical Margins After Nephron-Sparing Surgery
- (2011) Martin Marszalek et al. EUROPEAN UROLOGY
- A Non–Cancer-Related Survival Benefit Is Associated With Partial Nephrectomy
- (2011) Maxine Sun et al. EUROPEAN UROLOGY
- A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23
- (2011) Xifeng Wu et al. HUMAN MOLECULAR GENETICS
- Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
- (2011) Brian I Rini et al. LANCET
- Patient-Reported Outcomes in a Phase III Study of Everolimus Versus Placebo in Patients with Metastatic Carcinoma of the Kidney That Has Progressed on Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy
- (2011) J. L. Beaumont et al. ONCOLOGIST
- Quality of life in patients with advanced renal cell carcinoma treated with temsirolimus or interferon-α
- (2010) S Yang et al. BRITISH JOURNAL OF CANCER
- Family history of cancer and renal cell cancer risk in Caucasians and African Americans
- (2010) S Karami et al. BRITISH JOURNAL OF CANCER
- Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma
- (2010) D. Huang et al. CANCER RESEARCH
- Sunitinib Acts Primarily on Tumor Endothelium rather than Tumor Cells to Inhibit the Growth of Renal Cell Carcinoma
- (2010) D. Huang et al. CANCER RESEARCH
- Partial Nephrectomy Is Associated with Improved Overall Survival Compared to Radical Nephrectomy in Patients with Unanticipated Benign Renal Tumours
- (2010) Christopher J. Weight et al. EUROPEAN UROLOGY
- Age-Adjusted Incidence, Mortality, and Survival Rates of Stage-Specific Renal Cell Carcinoma in North America: A Trend Analysis
- (2010) Maxine Sun et al. EUROPEAN UROLOGY
- A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma
- (2010) Hendrik Van Poppel et al. EUROPEAN UROLOGY
- Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3
- (2010) Mark P Purdue et al. NATURE GENETICS
- The genetic basis of kidney cancer: a metabolic disease
- (2010) W. Marston Linehan et al. Nature Reviews Urology
- Epidemiology and risk factors for kidney cancer
- (2010) Wong-Ho Chow et al. Nature Reviews Urology
- Differential diagnosis of renal tumours with clear cell histology
- (2010) Victor E. Reuter et al. PATHOLOGY
- Quality of life in patients with metastatic renal cell carcinoma: The importance of patient-reported outcomes
- (2009) David Cella CANCER TREATMENT REVIEWS
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
- Guideline for Management of the Clinical T1 Renal Mass
- (2009) Steven C. Campbell et al. JOURNAL OF UROLOGY
- Renal cell carcinoma
- (2009) Brian I Rini et al. LANCET
- Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies
- (2009) Janice P. Dutcher et al. MEDICAL ONCOLOGY
- Smoking, environmental tobacco smoke, and risk of renal cell cancer: a population-based case-control study
- (2008) Ryan P Theis et al. BMC CANCER
- The VHL tumor suppressor and HIF: insights from genetic studies in mice
- (2008) P P Kapitsinou et al. CELL DEATH AND DIFFERENTIATION
- Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881
- (2008) Jan H.M. Blom et al. EUROPEAN UROLOGY
- Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206
- (2008) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Fat, Protein, and Meat Consumption and Renal Cell Cancer Risk: A Pooled Analysis of 13 Prospective Studies
- (2008) Jung Eun Lee et al. JNCI-Journal of the National Cancer Institute
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
- (2008) Andrew G Renehan et al. LANCET
- Statins Might Reduce Risk of Renal Cell Carcinoma in Humans: Case-Control Study of 500,000 Veterans
- (2008) Vikas Khurana et al. UROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started